nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
BI 853520, a FAK-Simile of Prior FAK Inhibitors?
|
Lee, Rachael Chang |
|
2019 |
14 |
1 |
p. 39-41 |
artikel |
2 |
Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
|
Deeks, Emma D. |
|
2019 |
14 |
1 |
p. 107-113 |
artikel |
3 |
Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer
|
Sammons, Sarah |
|
2018 |
14 |
1 |
p. 13 |
artikel |
4 |
Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy
|
Li, Zhuanglin |
|
2019 |
14 |
1 |
p. 93-105 |
artikel |
5 |
Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer
|
Sammons, Sarah |
|
2018 |
14 |
1 |
p. 1-12 |
artikel |
6 |
Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib
|
Hochmair, Maximilian J. |
|
2018 |
14 |
1 |
p. 75-83 |
artikel |
7 |
Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry
|
Chong, Li Chia |
|
2019 |
14 |
1 |
p. 85-91 |
artikel |
8 |
Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies
|
de Jonge, Maja J. A. |
|
2019 |
14 |
1 |
p. 43-55 |
artikel |
9 |
Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors
|
Doi, Toshihiko |
|
2019 |
14 |
1 |
p. 57-65 |
artikel |
10 |
Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx
|
Tsimafeyeu, Ilya |
|
2019 |
14 |
1 |
p. 33-38 |
artikel |
11 |
Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520
|
Verheijen, Remy B. |
|
2019 |
14 |
1 |
p. 67-74 |
artikel |
12 |
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG)
|
Font, Albert |
|
2019 |
14 |
1 |
p. 15-32 |
artikel |